David Priestley has extensive regulatory experience from roles in government, industry, trade association and with a specialist regulatory CRO. His particular skills are in supporting early product development and transition from preclinical to clinical phases and due diligence activities, with particular expertise in regulatory CMC requirements and clinical development of products in oncology and immunology, with emphasis on:
- Complete product life cycle regulatory affairs support, with specialisation in the early drug development/clinical phases
- Strategic drug development and regulatory affairs
- Clinical Trial and Marketing Authorisation support
P1